Title of article :
Percutaneous Interventions Alter the Hemostatic Profile of Patients With Unstable Versus Stable Angin
Author/Authors :
Shahram Yazdani MD، نويسنده , , Alan D. Simon MD، نويسنده , , Lance Kovar MD، نويسنده , , Weizheng Wang MD، نويسنده , , Allan Schwartz MD FACC، نويسنده , , LeRoy E. Rabbani MD FACC، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 1997
Abstract :
Objectives. The objectives of this study were to define the hemostatic profiles of patients with unstable angin compared with patients with stable angin and to investigate the effect of percutaneous interventions on the follow-up hemostatic profiles of these patients.
Background. Disturbances in hemostatic factors have been shown to be present in various clinical syndromes involving coronary artery disease. However, their role in stable angin versus unstable angin is less well defined.
Methods. We studied 61 patients with either stable or unstable angin undergoing percutaneous coronary interventions. Blood samples were drawn immediately before the intervention and at 1-month follow-up. Plasm levels of tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor-1 (PAI-1) and von Willebrand factor (vWF) were measured by enzyme-linked immunosorbent assays.
Results. Patients with unstable angin had significantly higher t-P levels (mean [±SE] 23.7 ± 3.4 vs. 14.3 ± 1.4 ng/ml, respectively, p = 0.02) and vWF antigen concentrations (2,231 ± 157 vs. 1,792 ± 108 mU/ml, respectively, p = 0.03) than patients with stable angina. No statistically significant differences were observed in the PAI-1 levels between the two groups (27.9 ± 5.5 vs. 21.4 ± 2.5 ng/ml, respectively, p = 0.25). At 1-month follow-up, there were no longer any significant differences in the t-P or vWF levels between the two groups (15.7 ± 1.2 vs. 13.6 ± 0.6 ng/ml, p = 0.13; 1,962 ± 170 vs. 1,809 ± 88 mU/ml, p = 0.39, respectively). There were no significant differences between the hemostatic profiles of patients undergoing percutaneous transluminal coronary angioplasty or coronary stenting initially and at 1-month follow-up.
Conclusions. These dat suggest that elevated plasm levels of t-P and vWF may correlate with instability of atheromatous plaques, and that their decrease after coronary interventions may reflect plaque reendothelialization and stabilization.
Keywords :
von Willebrand factor , VWF , tissue-type plasminogen activator , PTCA , PAI-1 , percutaneous transluminal coronary angioplasty , plasminogen activator inhibitor-1 , t-PA
Journal title :
JACC (Journal of the American College of Cardiology)
Journal title :
JACC (Journal of the American College of Cardiology)